Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNB2 | O95067 | 3/20 | 0.50 |
| ▸ | CDK1 | P06493 | 3/20 | 0.50 |
| ▸ | CCNB1 | P14635 | 3/20 | 0.50 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | CCR6 | P51684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TGM2 | P21980 | 2/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.37 |
| ▸ | BRD2 | P25440 | 2/20 | 0.37 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.37 |
| ▸ | PLK4 | O00444 | 1/20 | 0.37 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25684459 | 0.89 | CCNB2 (0.41) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25682888 | 0.88 | CCNB2 (0.48) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25684740 | 0.88 | CCNB2 (0.42) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25684468 | 0.87 | IDO1 (0.43) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25684472 | 0.85 | CCNB2 (0.39) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25683243 | 0.80 | HSP90AA1 (0.46) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25684743 | 0.80 | TGM2 (0.39) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL25686009 | 0.80 | HSP90AA1 (0.38) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL2826131 | 0.79 | CCNB2 (0.56) | CCNB2CDK1CCNB1CCNB3HSP90AA1 | |
| SCHEMBL2826129 | 0.79 | CCNB2 (0.56) | CCNB2CDK1CCNB1CCNB3HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023104170-A1 | COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS | HANGZHOU JIJING PHARMACEUTICAL TECHNOLOGY LIMITED (CN) | 2023-06-15 | — | — | WO | disclosed |
| US-20170157105-A1 | Anti-Viral Compounds | ABBVIE INC. (US) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157105-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | CCNB2 1328/4885CDK1 293/4885CCNB1 1064/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.